BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 25735365)

  • 1. End stage palliative care of head and neck cancer: a case study.
    Shishodia NP; Divakar DD; Al Kheraif AA; Ramakrishnaiah R; Pathan AA; Parine NR; Chandroth SV; Purushothaman B
    Asian Pac J Cancer Prev; 2015; 16(3):1255-8. PubMed ID: 25735365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Palliative Hypo-fractionated Radiotherapy in Locally Advanced Head and Neck Cancer with Fixed Neck Nodes.
    Paliwal R; Kumar-Patidar A; Walke R; Hirapara P; Jain S; Raj-Bardia M
    Iran J Cancer Prev; 2012; 5(4):178-82. PubMed ID: 25352967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypofractionated radiotherapy denoted as the "Christie scheme": an effective means of palliating patients with head and neck cancers not suitable for curative treatment.
    Al-mamgani A; Tans L; Van rooij PH; Noever I; Baatenburg de jong RJ; Levendag PC
    Acta Oncol; 2009; 48(4):562-70. PubMed ID: 19373698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short course palliative radiotherapy of 20 Gy in 5 fractions for advanced and incurable head and neck cancer: AIIMS study.
    Mohanti BK; Umapathy H; Bahadur S; Thakar A; Pathy S
    Radiother Oncol; 2004 Jun; 71(3):275-80. PubMed ID: 15172142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized phase I/II trial of two variants of accelerated fractionated radiotherapy regimens for advanced head and neck cancer: results of RTOG 88-09.
    Fu KK; Clery M; Ang KK; Byhardt RW; Maor MH; Beitler JJ
    Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):589-97. PubMed ID: 7790243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accelerated hypofractionation (OCTA SHOT): Palliative radiation schedule in advanced head and neck carcinoma.
    Jakhar SL; Purohit R; Solanki A; Murali P; Kothari T; Sharma N; Kumar HS
    J Cancer Res Ther; 2017; 13(6):943-946. PubMed ID: 29237955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of split-course hypofractionated palliative radiotherapy in head and neck cancer.
    Kancherla KN; Oksuz DC; Prestwich RJ; Fosker C; Dyker KE; Coyle CC; Sen M
    Clin Oncol (R Coll Radiol); 2011 Mar; 23(2):141-8. PubMed ID: 20934860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypofractionated radiotherapy for the palliation of advanced head and neck cancer in patients unsuitable for curative treatment--"Hypo Trial".
    Porceddu SV; Rosser B; Burmeister BH; Jones M; Hickey B; Baumann K; Gogna K; Pullar A; Poulsen M; Holt T
    Radiother Oncol; 2007 Dec; 85(3):456-62. PubMed ID: 18036689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 'QUAD SHOT'--a phase II study of palliative radiotherapy for incurable head and neck cancer.
    Corry J; Peters LJ; Costa ID; Milner AD; Fawns H; Rischin D; Porceddu S
    Radiother Oncol; 2005 Nov; 77(2):137-42. PubMed ID: 16260054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypofractionated, palliative radiotherapy for advanced head and neck cancer.
    Agarwal JP; Nemade B; Murthy V; Ghosh-Laskar S; Budrukkar A; Gupta T; D'Cruz A; Pai P; Chaturvedi P; Dinshaw K
    Radiother Oncol; 2008 Oct; 89(1):51-6. PubMed ID: 18649963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What Did the Pandemic Teach Us About Palliative Radiation in Head and Neck Cancer?
    Ghoshal S; Singla AK; Ballari N; Gupta A
    J Palliat Care; 2022 Jul; 37(3):317-322. PubMed ID: 34866493
    [No Abstract]   [Full Text] [Related]  

  • 12. Twice-weekly palliative radiotherapy for locally very advanced head and neck cancers.
    Murthy V; Kumar DP; Budrukkar A; Gupta T; Ghosh-Laskar S; Agarwal J
    Indian J Cancer; 2016; 53(1):138-41. PubMed ID: 27146764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of an RTOG phase III trial (RTOG 85-27) comparing radiotherapy plus etanidazole with radiotherapy alone for locally advanced head and neck carcinomas.
    Lee DJ; Cosmatos D; Marcial VA; Fu KK; Rotman M; Cooper JS; Ortiz HG; Beitler JJ; Abrams RA; Curran WJ
    Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):567-76. PubMed ID: 7790241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [SIB-IMRT radiotherapy given concomitantly with cisplatin for locally advanced squamous cell head and neck cancer (SCHNC). Evaluation of the early results and toxicity].
    Kiprian D; Jarząbski A; Pawłowska B; Michalski W; Kawecki A
    Otolaryngol Pol; 2011 Sep; 65(5 Suppl):117-25. PubMed ID: 22000261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retrospective study of palliative radiotherapy in newly diagnosed head and neck carcinoma.
    Stevens CM; Huang SH; Fung S; Bayley AJ; Cho JB; Cummings BJ; Dawson LA; Hope AJ; Kim JJ; O'Sullivan B; Waldron JN; Ringash J
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):958-63. PubMed ID: 20950952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
    Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anemia is associated with decreased survival and increased locoregional failure in patients with locally advanced head and neck carcinoma: a secondary analysis of RTOG 85-27.
    Lee WR; Berkey B; Marcial V; Fu KK; Cooper JS; Vikram B; Coia LR; Rotman M; Ortiz H
    Int J Radiat Oncol Biol Phys; 1998 Dec; 42(5):1069-75. PubMed ID: 9869231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction chemotherapy followed by concurrent chemoradiation in advanced squamous cell carcinoma of the head and neck: final results from a phase II study with docetaxel, cisplatin and 5-fluorouracil with a four-year follow-up.
    Rapidis AD; Trichas M; Stavrinidis E; Roupakia A; Ioannidou G; Kritselis G; Liossi P; Giannakouras G; Douzinas EE; Katsilieris I
    Oral Oncol; 2006 Aug; 42(7):675-84. PubMed ID: 16731029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is a surgical resection leaving positive margins of benefit to the patient with locally advanced squamous cell carcinoma of the head and neck: a comparative study using the intergroup study 0034 and the Radiation Therapy Oncology Group head and neck database.
    Laramore GE; Scott CB; Schuller DE; Haselow RE; Ervin TJ; Wheeler R; al-Sarraf M; Gahbauer RA; Jacobs JR; Schwade JG
    Int J Radiat Oncol Biol Phys; 1993 Dec; 27(5):1011-6. PubMed ID: 8262821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metronomic palliative chemotherapy in locally advanced, recurrent and metastatic head-and-neck cancer: A single-arm, retrospective study of a regional cancer center of North India (Asia).
    Harsh KK; Maharia SR; Nirban RK; Khatri P; Beniwal S; Kumar HS; Jakhar SL
    J Cancer Res Ther; 2020; 16(3):559-564. PubMed ID: 32719267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.